81277 Cytogenomic neo microra alys
Also known as: Cancer microarray analysis, oncologic CNV testing
Cytogenomic microarray analysis for copy number variations and chromosomal abnormalities in neoplastic specimens using fluorescent probes.
In Plain Language
Cancer chromosome mapping; Tumor genetic abnormality test
Clinical Context
Detects chromosomal gains and losses in malignant tumors to guide prognosis, treatment selection, and identify fusion genes.
RVU Information
CPT 81277 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81277?
CPT 81277 (Cytogenomic neo microra alys) is a Pathology & Lab code. Cytogenomic microarray analysis for copy number variations and chromosomal abnormalities in neoplastic specimens using fluorescent probes.
Who uses CPT code 81277?
CPT 81277 is used by Pathology, Oncology, Genetics. Detects chromosomal gains and losses in malignant tumors to guide prognosis, treatment selection, and identify fusion genes.
When is CPT 81277 used?
Detects chromosomal gains and losses in malignant tumors to guide prognosis, treatment selection, and identify fusion genes.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.